In this article, the authors used Biological Dynamic ACE technology to demonstrate the ability to isolate glioblastoma exosomes from undiluted plasma and detect proteins and RNA bound to the exosomes.
Read MoreIn this article, the authors used Biological Dynamic ACE technology to demonstrate the ability to isolate glioblastoma exosomes from undiluted plasma and detect proteins and RNA bound to the exosomes.
Read MoreBiological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.